Viatris Inc.
NASDAQ:VTRSDrug Manufacturers - Specialty & Generic
-$0.36 today
- Market cap
- $23.25B
- Beta
- 0.90
- P/E (TTM)
- -59.9
- EPS (TTM)
- -$0.26
- Dividend yield
- 3.12%
Volume 13.21M
Average 10.58M
VTRS Cash & Equivalents
Cash on hand and highly liquid investments that can be converted to cash almost immediately.
Viatris Inc.NASDAQ: VTRS
Cash & Equivalents · Q2 FY2026 · quarter ended Jun 2026
Cash & equivalents rises 56.5% from a year ago
Cash & equivalents stood at $886.5M at the end of Q2 FY2026, up 56.5% from a year earlier and down 50.9% from the prior quarter. Over 3 fiscal years it compounded at +2.3% a year.
Context
- Cash & equivalents amounted to 2.5% of total assets at the end of Q2 FY2026, up 1.1 pp from a year earlier.
- Cash & equivalents increased in 1 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether cash & equivalents keeps rising in the next quarterly balance sheet after a +56.5% change from a year earlier.
Sources:Balance SheetText generated from reported figures; not investment advice.
Cash & Equivalents history
USD · from the balance sheet
- Latest · FY2025
- 1.35B USD
- Year-over-year change
- +83.5%
- 4-year CAGR
- +17.8%
| Period | Period end | Cash & Equivalents | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 1.35B | +83.5% |
| FY2024 | 2024-12-31 | 734.8M | -25.9% |
| FY2023 | 2023-12-31 | 991.9M | -21.3% |
| FY2022 | 2022-12-31 | 1.26B | +79.7% |
| FY2021 | 2021-12-31 | 701.2M | — |
Cash & Equivalents vs competitors
How VTRS compares with its peers on the latest reported figures
- Peers report in different currencies, so cash & equivalents is compared through growth and share of total assets rather than absolute size.
- Its year-over-year change of +56.5% is the 5th highest of 10, against a peer median of +34.8%.
- Cash & equivalents amounts to 2.5% of total assets for VTRS, versus a peer median of 9.2%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Sep 2026 | ₹13.35B INR | +34.8% | +37.6% | 2.3% | |
| Jun 2026 | $3.66B USD | +69.1% | +8.3% | 9.2% | |
| Jun 2026 | $1.83B USD | +5.7% | +32.9% | 7.4% | |
| Sep 2026 | $1.46B USD | +116.5% | -6.7% | 10.9% | |
| Dec 2025 | £1.32B GBP | -39.8% | +24.6% | 4.1% | |
| Jun 2026 | $886.5M USD | +56.5% | +2.3% | 2.5% | |
| Sep 2026 | $631.31M USD | +2.4% | +56.4% | 14.2% | |
| Mar 2026 | $311.18M USD | +107.7% | +80.9% | 21.9% | |
| Mar 2026 | $171.17M USD | -6.4% | +2.9% | 10.4% | |
| Jun 2026 | $127.64M USD | +57.2% | +128.7% | 3.4% | |
| Peer median (excluding VTRS) | — | +34.8% | +32.9% | 9.2% | |
Competitors are the stored peer set for VTRS. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Cash & Equivalents | 701.2M | 1.26B | 991.9M | 734.8M | 1.35B |
| Short-term Investments | 233.8M | 212.6M | 192.5M | 355.1M | 106.4M |
| Net Receivables | 4.27B | 4.14B | 4.04B | 3.52B | 3.35B |
| Inventory | 3.98B | 3.52B | 3.47B | 3.85B | 4B |
| Other Current Assets | 1.47B | 1.31B | 4.13B | 913.8M | 194.8M |
| Total Current Assets | 10.9B | 10.64B | 12.98B | 9.52B | 9.22B |
| Property, Plant & Equipment (Net) | 3.48B | 3.28B | 3.01B | 2.92B | 2.89B |
| Goodwill | 12.11B | 10.43B | 9.87B | 9.13B | 6.75B |
| Intangible Assets | 26.13B | 22.61B | 19.18B | 17.07B | 15.1B |
| Long-term Investments | 81.4M | 1.09B | 1.14B | 1.35B | 815M |
| Tax Assets | 1.33B | 925.9M | 692.9M | 753M | 1.06B |
| Other Non-current Assets | 798.5M | 1.05B | 821.1M | 754M | 1.35B |
| Total Non-current Assets | 43.94B | 39.39B | 34.71B | 31.98B | 27.97B |
| Total Assets | 54.84B | 50.02B | 47.69B | 41.5B | 37.19B |
| Account Payables | 1.06B | 1.16B | 1.38B | 1.36B | 1.29B |
| Short-term Debt | 3.35B | 1.25B | 1.93B | 600K | 2.04B |
| Tax Payables | 236.9M | 279.6M | 226.8M | 192.7M | 0 |
| Deferred Revenue | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 1.41B | 1.24B | 1.41B | 1.34B | 2.88B |
| Total Current Liabilities | 9.88B | 6.75B | 7.78B | 5.78B | 7.09B |
| Long-term Debt | 19.72B | 18.02B | 16.19B | 14.04B | 12.48B |
| Deferred Tax Liabilities | 2.82B | 2.43B | 1.74B | 1.11B | 892M |
| Deferred Revenue (Non-current) | 0 | 0 | 0 | 0 | 0 |
| Other Non-current Liabilities | 1.73B | 1.58B | 1.35B | 1.76B | 1.84B |
| Total Non-current Liabilities | 24.47B | 22.2B | 19.44B | 17.09B | 15.39B |
| Total Liabilities | 34.35B | 28.95B | 27.22B | 22.87B | 22.48B |
| Common Stock | 12.1M | 12.1M | 12.2M | 12.3M | 12.5M |
| Retained Earnings | 3.69B | 5.18B | 4.64B | 3.42B | (388.3M) |
| Accumulated OCI | (1.74B) | (2.76B) | (2.75B) | (3.21B) | (2.71B) |
| Other Stockholders Equity | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 |
| Total Equity | 20.49B | 21.07B | 20.47B | 18.64B | 14.71B |
| Total Debt | 23.36B | 19.53B | 18.37B | 14.31B | 14.7B |
| Net Debt | 22.66B | 18.27B | 17.38B | 13.57B | 13.35B |
Viatris Inc.
NASDAQ:VTRS
Intrinsic Alpha fair value
Locked
Current Price
$20.28
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.